Navigation Links
Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
Date:4/30/2009

n will host a conference call and webcast today at 8:30 a.m. Eastern Daylight Time to discuss first quarter 2009 results, the outlook for 2009 and recent corporate developments. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573. A taped replay of the call will be available by calling (800) 642-1687 with access pass code 96139762. The replay may be accessed from international locations by dialing (706) 645-9291 and using the same pass code. This replay will remain in effect until midnight Eastern Daylight Time, May 15, 2009. To access the live webcast, go to Watson's Investor Relations Web site at http://ir.watson.com.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Statements contained in this press release that refer to Watson's estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. For instance, any statements in this press release concerning prospects related to Watson's strategic initiatives, product introductions and anticipated financial performance are forward-looking statements. It is important to note that Watson's goals and expectations are not predictions of actual performance. Watson's performance, at times, will differ from it
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the research, development and ... approved all three resolutions that the Company had proposed at the Annual General Meeting of ... Description of Votes ... Votes Non-, ... For Against ...
(Date:12/15/2009)... Lourdes Health Care Services Inc., the parent company of ... United States $7.95 million to resolve allegations that the ... two hospitals are Our Lady of Lourdes Medical Center ... Burlington County (LMC) in Willingboro, N.J. ,, LMC ... whistleblower, Tony Kite, in 2005. The lawsuit alleged that ...
(Date:12/15/2009)... than needed for protection, CDC says, , , TUESDAY, Dec. ... H1N1 swine flu vaccine have been recalled by manufacturer ... federal health officials said Tuesday. , According to the ... routine testing of the vaccine for children aged 6 ... had lower than required potency levels. "This means that ...
(Date:12/15/2009)... 15 4R Systems, Inc., a leading ... which help retailers significantly increase profits by optimizing ... today that The Vitamin Shoppe has been utilizing ... store and DC inventory solutions have helped us ... in-stocks over the last two years," said Tony ...
(Date:12/15/2009)... Mass., Dec. 15 North American application ... in November year-over-year, according to the MIB ... insurance applications over the past three months have ... levels of -1.6%, to flat at November,s close, ... their interest in the benefits available from life ...
Breaking Medicine News(10 mins):Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... Friendship All Natural Cottage Cheese and NBC 10 Seek the ... in This Year,s ... a 46-year-old massage,therapist, a 35-year-old administrative assistant, a 41-year-old comedian,and ... a,43-year-old substitute teacher have in common? They,re all contestants in,"The ...
... Sex Lives Exciting, ATLANTA, Sept. 25 Americans ... less than one hour on foreplay and,sexual intercourse. No ... as,exciting. And while there are several factors influencing ... On average, Americans spend 35 minutes on foreplay ...
... the U.S. to earn trusted ... symbol of safety and effectiveness, CHICAGO, Sept. 25 ... Orbit(R), Extra(R) and Eclipse(R),sugar-free chewing gums have earned the universally trusted ... the,first and only gums in the U.S. to earn this recognition ...
... find it,s tougher than ever for youngsters to stay healthy, ... little movement, too much TV exposure and way too much ... overweight and obesity, a collection of new studies finds. , ... American Journal of Preventive Medicine -- show the ...
... sector hospitals could be dictating how and when babies are ... of elective, planned caesarean sections rises, more and more babies ... world at weekends. It appears that hospitals schedule births during ... working normal hours at no extra cost. These findings by ...
... Car Driver Promotes Educational ... People in Chronic Pain, LAGUNA SECA, Calif., Sept. 25 ... this weekend when Mike Roman competes,in a Sports Car Club ... leg was amputated 12 years ago, will race Saturday,September 29th ...
Other Medicine News:Health News:Five Local Residents Vie to be Philadelphia's Biggest 2007 'Local Loser' 2Health News:Five Local Residents Vie to be Philadelphia's Biggest 2007 'Local Loser' 3Health News:Five Local Residents Vie to be Philadelphia's Biggest 2007 'Local Loser' 4Health News:Americans Not Making Time for Making Love 2Health News:Americans Not Making Time for Making Love 3Health News:Americans Not Making Time for Making Love 4Health News:Wrigley's Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Association's Seal of Acceptance 2Health News:Wrigley's Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Association's Seal of Acceptance 3Health News:Wrigley's Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Association's Seal of Acceptance 4Health News:Junk Food, TV Driving Kids to Obesity 2Health News:Junk Food, TV Driving Kids to Obesity 3Health News:Junk Food, TV Driving Kids to Obesity 4Health News:Weekend labor shortage 2Health News:Race Against Pain Coming to California 2Health News:Race Against Pain Coming to California 3
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that ... notice (the "Notice") executed by the Marc S. Hermelin ... requesting that the Board of Directors of the Company ... by written consent relating to the proposed appointment of ... from Ronald J. Kanterman,s departure (the "Director Appointment"). ,, ...
(Date:12/15/2009)... PITTSBURGH, Dec. 15 Ever wonder what something ... samples! ASPEX, makers of the Personal Scanning Electron Microscope ... encouraging people to send in samples to be scanned ... PSEM has a scan range of 100nm to 5mm ... the smallest samples into focus. In addition, ASPEX will ...
(Date:12/15/2009)... the best plan at the right price ... end of the year, thousands of Nebraska Medicare beneficiaries ... This is when the state,s 268,000 Medicare beneficiaries ... up and pay for in 2010. ,, Prescription ... says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2GSK to Announce Q2 Results July 22 2009 51962 1Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 1Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 2Nile Therapeutics Inc Completes 243 4 Million Private Placement 13072 3Immucor Appoints Chief Operating Officer 51955 1Immucor Appoints Chief Operating Officer 51955 2
... SUNNYVALE, Calif., June 27, 2007,/PRNewswire-FirstCall/ -- Pharmacyclics, ... multi-center Phase 2,clinical trials supporting the potential ... lead product,candidate, in combination with Alimta(R) (pemetrexed) ... second-line treatment,for patients with non-small cell lung ...
... OSS, the Netherlands, June 27, 2007-Organon, the human,healthcare ... two,out of three Phase III clinical trials with ... have reached,their randomization target. , ,Corifollitropin alfa ... first of a new class of gonadotropins (a ...
Other Medicine Technology:Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
The cemented hip joint prosthesis system....
The Quatroloc primary hip system offers 35 primary stems to fit almost all femurs for primary hip arthroplasty....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat...
Medicine Products: